Transforming Growth Factor β: Potential Autocrine Growth Inhibitor of Estrogen Receptor-negative Human Breast Cancer Cells

Cancer Research

Volumn 48, Issue 14, 1988, Pages 3898-3904

  Arteaga, Carlos L ^a   Tandon, Atul K ^a   Von Hoff, Daniel D ^a   Osborne, C Kent ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; TRANSFORMING GROWTH FACTOR BETA;

BREAST CANCER; CELL CULTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL;

AFFINITY LABELS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; HUMAN; KINETICS; MOLECULAR WEIGHT; PEPTIDES; RECEPTORS, ESTROGEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTORS;

EID: 0023676353     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tucker, R. F., Volkenant, M. E., Branum, E. L., and Moses, E. L. Comparison of intra- and extracellular transforming growth factors from nontrans-formed and chemically transformed mouse embryo cells. Cancer Res., 43: 1581-1586,1983.
2. Roberts, A. B., Anzano, M. A., Lamb, L. C., Smith, J. M., and Sporn, M. B. New class of transforming growth factors potentiated by epidermal growth factor isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA, 78: 5339-5343,1981.
3. Roberts, A. B., Anzano, M. A., Meyers, C. A., Wideman, J., Blancher, R., Pan, Y-C. E., Stein, S., Lehrman, S. R., Smith, J. M., Lamb, L. C., and Sporn, M. B. Purification and properties of a type β transforming growth factor from bovine kidney. Biochemistry, 22:5692-5698,1983.
4. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., and Sporn, M. B. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J. Biol. Chem., 258: 7155-7160,1983.
5. Frolik, C. A., Dart, L. L., Meyers, C. A., Smith, D. M., and Sporn, M. B. Purification and initial characterization of a type β transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA, 80: 3676–3680, 1983.
6. Seyedin, S. M., Thompson, A. Y., Bentz, H., Rosen, D. M., McPherson, J. M., Conti, A., Siegel, N. R., Galluppi, G. R., and Piez, K. A. Cartilage-inducing factor-A: apparent identity to transforming growth factor-β. J. Biol. Chem., 261:5693-5695,1986.
7. Anzano, M. A., Roberts, A. B., DeLarco, J. E., Wakefield, L. M., Assoian, R. K., Roche, N. S., Smith, J. M., Lazarus, J. E., and Sporn, M. B. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol. Cell Biol., 5; 242-247,1985.
8. Dickson, R. B., Bates, S. E., McManaway, M. E., and Lippman, M. E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res., 46:1707-1713,1986.
9. Coffey, R. J., Shipley, G. D., and Moses, H. L. Production of transforming growth factors by human colon cancer lines. Cancer Res., 46: 1164–1169, 1986.
10. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., and Sporn, M. B. Type β transforming growth factor a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA, 82:119-123,1985.
11. Moses, H. L., Tucker, R. F., Leof, E. B., Coffey, R. J., Halper, J., and Shipley, G. D. Type-β transforming growth factor is a growth stimulator and a growth inhibitor. In: J. Feramisco, B. Ozanne, and C. Stiles, (eds.), Cancer Cells, Vol. 3, pp 65–71. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1985.
12. Tucker, R. F., Branum, E. L., Shipley, G. D., Ryan, R. J., and Moses, H. L. Specific binding to cultured cells of 125I-labeled type β transforming growth factor from human platelets. Proc. Natl. Acad. Sci. USA, 81: 6757–6761, 1984.
13. Masague, J., and Like, B. Cellular receptors for type β transforming growth factor ligand binding and affinity labeling in human rodent cell lines. J. Biol. Chem., 260:2636-2645,1985.
14. Masague, J. Subunit structure of a high-affinity receptor for type β transforming growth factor. Evidence of a disulfide-linked glycosylated receptor complex. J. Biol. Chem., 260:7059-7066,1985.
15. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., and Dickson, R. B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48:417-428,1987.
16. Tucker, R. J., Shipley, G. D., Moses, H. L., and Holley, R. W. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science (Wash. DC), 226:705-707,1984.
17. Wakefield, L. M., Smith, D. M., Masui, T., Harris, C. C., and Sporn, M. B. Distribution and modulation of the cellular receptors for transforming growth factor-beta. J. Cell Biol., 105:965-975,1987.
18. Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., and Goeddel, D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature (Lond.), 316:701-705,1985.
19. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors a and β in the epidermal growth factor receptor by human tumors. Cancer Res., 47:707-712,1987.
20. Frolik, C. A., Wakefield, L. M., Smith, D. M., and Sporn, M. B. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem., 259:10995-11000,1984.
21. Osborne, C. K., Bolan, G., Monaco, M. E., and Lippman, M. E. Hormone responsive human breast cancer in long term tissue culture: effect of insulin. Proc. Natl. Acad. Sci. USA, 73:4536-4540,1976.
22. Masague, J., and Kelly, B. Internalization of transforming growth factor-β and its receptor in Balb/C 3T3 fibroblasts. J. Cell. Physiol., 128: 216–222, 1986.
23. Kazlauskas, A. D., and DiCorleto, P. E. Cultured endothelial cells do not respond to a platelet-derived growth-factor-like protein in an autocrine manner. Biochim. Biophys. Acta, 846:405-412,1985.
24. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature (Lond.), 227:680-685,1970.
25. Osborne, C. K., Hobbs, K., and Trent, T. M. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat, 9:111-121,1987.
26. Knight V. A., Livingston, R. B., Gregory, E. J., and McGuire, W. L. Estrogen receptor is an independent prognostic factor for early recurrence in breast cancer. Cancer Res., 37:4669-4671,1977.
27. Moran, R., Black, M., and Alpert, L. Correlation of cell cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer (Phila.), 54:1586-1590,1984.
28. McGuire, W. L., and Dressier, L. G. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J. Natl. Cancer Inst., 75:405-410,1985.
29. Salomon, D. S., Zwiebel, J. A., Bano, M., Losonczy, I., Fehnel P., and Kidwell, W. R. Presence of transforming growth factors in human breast cancer cells. Cancer Res., 44:4069-4077,1984.
30. Huff, K. K., Kaufman, D., Gabbay, K. H., Spencer, E. M., Lippman, M. E., and Dickson, R. B. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res., 46:4613-4619,1986.
31. Pircher, R., Lawrence, D. A., and Jullien, P. Latent β-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res., 44:5538-5543,1984.
32. Lawrence, D. A., Pircher, R., Kryceve-Martinerie, C., and Jullien, P. Normal embryo fibroblasts release transforming growth factors in a latent form. J. Cell. Physiol., 12:184-188,1984.
33. Wakefield, L. M., Smith, D. M., Flanders, K. C., and Sporn, M. B. Characterization of a latent form of transforming growth factor-β secreted by human platelets. J. Cell. Biochem., 11A(Suppl.): 46, 1987.